WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The ...
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the ...
The platform can reduce lentiviral vector production timelines from 18 months to less than 7 months Charles River provides viral vector production services ranging from clone construction through good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results